Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - Annals of Oncology
Long-Term Outcomes After High-Dose Postprostatectomy Salvage Radiation Treatment - International Journal of Radiation Oncology, Biology, Physics
Abiraterone Acetate for Adenocarcinoma Clinical Trial 2022 | Power
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the place
Prostate cancer screening—when to start and how to screen? - Kohestani - Translational Andrology and Urology
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial - The Lancet Oncology
Cureus | Prognostic Factors for Prostate Cancer Endpoints Following Biochemical Failure: A Review of the Literature
Diagnostics | Free Full-Text | 68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy | HTML
International Braz J Urol ::
Day 3,508 – PSA Results | Dan's Journey through Prostate Cancer
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - ScienceDirect
Roundtable Discussion: Morgans Addresses How PSA Levels Affect Nonmetastatic CRPC Treatment
PSA Doubling Time Calculator
GitHub - conan-koh123/Calculating-PSA-Doubling-Time-for-many-patients: R code to calculate PSA doubling time (in months) for many patients
Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
International Braz J Urol ::
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - Annals of Oncology
Summary of PSA Doubling Time and Velocity Definitions | Download Table
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Proposal for a Standardized PSA Doubling-time Calculation
Staff Member CV - Memorial Sloan Kettering Cancer Center
The PSA-doubling time in patients with different rate of prostate... | Download Table
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
PDF) Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
Variations in PSA doubling time in patients with prostate cancer on “watchful waiting”: Value of short-term PSADT determinations - Urology
